Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma
- Sujana Movva
- , Kenneth Seier
- , Martina Bradic
- , Karmelina Charalambous
- , Evan Rosenbaum
- , Ciara M Kelly
- , Seth M Cohen
- , Martee L Hensley
- , Viswatej Avutu
- , Lauren B Banks
- , Jason E Chan
- , Ping Chi
- , Sandra D’Angelo
- , Mark A Dickson
- , Mrinal M Gounder
- , Mary L Keohan
- , Robert G Maki
- , Angela Green
- , Vicky Makker
- , Maria M Rubinstein
- , Sara Saunds
- , Jae-Mun Cho
- , Robert A Lefkowitz
- , Joseph Erinjeri
- , Li-Xuan Qin
- , Ronak Shah
- , Phillip Wong
- , William Tap
No endorsements
This article has not been endorsed yet.
Like this work?
Let others know. Sign in to add your endorsement.